Institutional shares held 106 Million
139K calls
604K puts
Total value of holdings $189M
$248K calls
$1.08M puts
Market Cap $119M
66,551,600 Shares Out.
Institutional ownership 158.54%
# of Institutions 183


Latest Institutional Activity in ESPR

Top Purchases

Q2 2025
Pender Fund Capital Management Ltd. Shares Held: 6.68M ($12M)
Q2 2025
Two Seas Capital LP Shares Held: 9.95M ($17.8M)
Q2 2025
Marshall Wace, LLP Shares Held: 5.31M ($9.51M)
Q2 2025
Royal Bank Of Canada Shares Held: 1.17M ($2.09M)
Q2 2025
Ubs Group Ag Shares Held: 1.54M ($2.75M)

Top Sells

Q2 2025
Morgan Stanley Shares Held: 1.06M ($1.89M)
Q2 2025
Nuveen, LLC Shares Held: 423K ($756K)
Q2 2025
Wells Fargo & Company Shares Held: 123K ($221K)
Q2 2025
Two Sigma Investments, LP Shares Held: 1.83M ($3.27M)
Q2 2025
State Street Corp Shares Held: 3.76M ($6.73M)

About ESPR

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.


Insider Transactions at ESPR

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.65M Shares
From 9 Insiders
Grant, award, or other acquisition 1.65M shares
Sell / Disposition
101K Shares
From 4 Insiders
Open market or private sale 101K shares

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Track Activities on ESPR